An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as cimetidine and ranitidine. It is generally well tolerated by patients. .

Leblon - Pharmacology:

Leblon is a muscarinic receptor antagonist and binds to the muscarinic acetylcholine receptor. The muscarinic acetylcholine receptor mediates various cellular responses, including inhibition of adenylate cyclase, breakdown of phosphoinositides and modulation of potassium channels through the action of G proteins.

Leblon for patients

Patient Information:

Check with your doctor before you take Leblon. It may cause blurry vision and dizziness, which may affect driving, operating machinery and other
activities. It may also cause dryness of the mouth, nose and throat.
Do not change the dose or stop Leblon without consulting your doctor. The dose of Leblon needs to reduced gradually to prevent the
withdrawal side effects.

Leblon Interactions

Drug Interactions:

Leblon may interact with the following drugs, which may affect the effect of Leblon or whose effects may be affected.
- Antacids
- Diarrhea medicine containing kaolin or attapulgite
- Ketoconazole
- Central nervous system (CNS) depressants
- Other anticholinergics
- Tricyclic antidepressants (e.g., Elavil, Asendin, Anafranil, Pertofrane, Sinequan, Tofranil, Aventyl, Surmontil)
- Potassium chloride (e.g., Kay Ciel)

Generic name, Overdose, Half Life Leblon, Food Interactions, Chemical, etc..

Leblon see also

Brand Names containing Pirenzepine